EU to have received 107 mn vax doses by end of week European Union member states will have received a total of 107 million doses of coronavirus vaccine by the end of this week, a European Commission spokeswoman said Wednesday. Mar 31, 2021 0 0
EU agency finds no specific age risk for AstraZeneca so far Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are carrying out further analysis, the EU's drug regulator said Wednesday. Mar 31, 2021 0 2
Turning back the clock on a severe vision disorder Gustavo Aguirre and William Beltran, veterinary ophthalmologists and vision scientists at the University of Pennsylvania School of Veterinary Medicine, have studied a wide range of different retinal blinding disorders. But ... Mar 31, 2021 0 40
Jump in cancer diagnoses at 65 implies patients wait for Medicare, according to study Analyzing a national cancer database, researchers find a bump in diagnoses at 65, suggesting that many wait for Medicare to kick in before they seek care. Mar 31, 2021 0 8
Comprehensive report on pandemic response solutions developed by 180 leading experts When the World Health Organization declared the COVID-19 outbreak a pandemic, the health crisis catalyzed a global effort to accelerate innovation and stop the novel virus's spread. To help streamline that effort, the MIT ... Mar 31, 2021 0 0
FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure for a devastating hereditary disorder, sickle cell disease, ... Mar 31, 2021 0 5
Video: Why do some people have side effects with COVID-19 vaccines while others do not? After getting the COVID-19 vaccine, some people develop a low-grade fever, fatigue, headache, and/or muscle aches, while others have no symptoms at all. Mar 31, 2021 0 9
Fooling coronavirus with new decoy protein renders it impotent A novel decoy protein designed by Northwestern Medicine scientists fools SARS-CoV-2 by intercepting the spike of the coronavirus and rendering it impotent. Mar 31, 2021 0 8
Studying the spread of a virtual, safe epidemic Vital information on how COVID-19 spreads though communities will soon be gleaned from a real-life trial of The University of Queensland-led Safe Blues program and app. Mar 31, 2021 0 10
More Detroiters 'very likely' to get COVID-19 vaccine than 4 months ago, survey finds Thirty-eight percent of Detroiters now say they are "very likely" to get the COVID-19 vaccine when it becomes available, up from 14% who gave that response in fall 2020, according to a new survey from the University of Michigan. Mar 31, 2021 0 2